Clinical Trials Browser

Phase 1 × Advanced/Metastatic Solid Tumors × pembrolizumab × Clear all

NCT05277402 2024-02-26

ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors